Abstract. Diacylglycerol kinase (DGK) is an enzyme that converts diacylglycerol to phosphatidic acid. To date, 10 isoforms of DGKs (a, b, g, d, e, z, h, q, i, and k) have been identified in mammals, and these DGKs show characteristic expression patterns and roles. The expression levels of DGKs are comparatively higher in the central nervous system than in other organs and may play several important roles in regulating higher brain functions. Currently, many studies have been performed to reveal the roles of DGKs by knocking down or overexpression of DGKs in vitro. Additionally, knockout or overexpression mice of several DGKs have been generated, and phenotypes of these mice have been studied. In this review, we discuss the roles of DGKs in the central nervous system based on recent findings in genetic models.
Introduction
After Gq protein-coupled receptors are stimulated, phospholipase C is activated and produces diacylglycerol (DG) from inositol phospholipids (1). DG is an essential second messenger in mammalian cells and plays impor tant roles in gene transcription, lipid signaling, cyto skeletal dynamics, intracellular membrane trafficking, and neurotransmitter release (2, 3).
Diacylglycerol kinase (DGK) is an enzyme that phos phorylates DG to phosphatidic acid (PA), which means that DGK terminates DG signaling and initiates PA signaling. Similarly to DG, PA also regulates various types of intracellular signaling such as mammalian target of rapamycin and Raf1 kinase (4 -6). From these reports, DGK is one of the main molecules regulating intracellular signaling. To date, 10 mammalian DGKs have been identified (7 -16) . DGKs are known to be strongly expressed in the central nervous system, but the expression patterns are different for each isoform (17 -20) . Additionally, each DGKs isoform has a distin guishing localization in cells (21, 22) , suggesting that DGKs play unique roles in each isoform.
To demonstrate the functions of DGKs, many studies have been performed using a genetic approach in vitro and in vivo. To date, several overexpression or knockout (KO)mice have been generated by many research groups: DGKaKO (23) , cardiacspecific overexpression of DGKa (24) , DGKbKO (25) , DGKdKO (26) , DGKe KO (27) , DGKzKO (28) , and DGKiKO mice (29) . From the phenotypes of these DGKKO mice, each DGK has been shown to play an important roles in regulating various neuronal functions such as cognitive functions (25, 30, 31) , mood (32) , and resistance to excitatory stimuli (33 -35) .
In this review, we discuss the roles of DGKs in the central nervous system from recent findings employing genetic models and mention the possibility of involve ment in several diseases.
Isoforms of DGKs and their classification
To date, 10 mammalian DGKs have been identified (7 -16, 36), and they are classified into five types (Fig. 1) (38) . The SAM domain binds zinc at multiple sites and cause the oligomarization of type II DGKs (39 -41) . Furthermore, both the SAM and Nterminal PH domains of DGKd are needed to exert their own effects on endoplasmic reticulumtoGolgi traffic (42) .
DGKe is the only type III isoform; it possesses a hydrophobic domain (43) and differs in showing the selectivity for acyl chains (44, 45) .
DGKz and i are classified as type IV DGKs. They contain myristoylated alaninerich protein kinase C sub strate (MARCKS), PDZbinding, and ankyrin domains. The MARCKS domain is homologous to the phosphory lationsite domain (PSD) of the MARCKS protein and regulates the nuclear localizations of DGKz (46, 47) . The PDZbinding and ankyrin domains of DGKz regulate interactions with several proteins (48 -51) .
DGKq is classified as type V DGK and possesses three cysteinerich domains and a PHlike domain (16) .
Type I DGKs in the central nervous system

DGKa
In the central nervous system, type I DGK is expressed in various regions (Table 1) . DGKa was isolated from a rat brain cDNA library by Goto et al. (7) and was found to be expressed specifically in the oligodendrocytes, but not neurons. Gene expression profiling of a mouse brain has shown that DGKa is expressed throughout the entire brain (17) . In the retinas, DGKa is also expressed in ganglion cells in the ganglion cell layer (GCL) and inner plexiform layer (IPL) (18) .
DGKa KO mice were generated by Olenchock et al. (23) and actively used to investigate the involvement of DGKa in the immune system (23, 52, 53) . There are no differences in the birth rate, body weight, and normal behavior (such as locomotor activity, anxiety levels, and cognitive functions) between DGKa KO and wildtype mice (unpublished data, M. Ishisaka, Y. Shirai, and H. Hara). However, the inflammatory response is also involved in various diseases of the central nervous systems (54) ; therefore DGKa KO mice might show unique phenotypes under conditions of stress.
DGKb
DGKb is strongly expressed in the olfactory bulb, cortex, striatum, and hippocampus, but not in the thalamus, hypothalamus, or most brainstem nuclei (Table 1) ; its expression is detected mainly in neurons (8). In the retinas, DGKb is strongly expressed in the rod and cone bipolar cells and horizontal cells of the outer plexiform layer (OPL) and moderately expressed in the inner nuclear layer (INL) and IPL (18) .
DGKb KO mice were generated by Shirai et al. in 2010 (25) . Based on their behavioral analysis, DGKb KO mice exhibit cognitive impairment, manialike behavior, and increased seizure susceptibility (25, 32, 55) . DGKb has been reported to show unique membrane localization and its expression levels in rat brains rapidly increases after postnatal day 14 (56, 57) , when synaptic formation is progressing. In the hippocampus and striatum, DGKb is accumulated at the perisynapse of dendritic spines (58, 59) . In the hippocampus of DGKb KO mice, the numbers of spines and spine junction are lower than those of wildtype mice, with decreasing PA content and increasing DG content (Fig. 2) . Additionally, in the primary cultured hippocampal neurons from DGKb KO mice, branching and spine formation have been found to be decreased and ameliorated by DGKb over 
Double circle, strongly expressed; Circle, moderately or weakly expressed; N.D., not detected. expression (25) . These results suggest that DGKb plays an important role in synaptic formations, which is consistent with another study (59) . In the hippocampal CA3 area of DGKb KO mice, the numbers of parvalbuminpositive interneurons decreased, which may contribute to the increment of seizure susceptibility toward kainic acid and pentylene tetrazol (55) . In the cortex of DGKb KO mice, cortical spine density has been found to be significantly decreased and AktGSK3b signaling was impaired, which may be a strong contributor to manialike behavior such as hyperlocomotion, reduced anxiety, and reduced depres sion (32) . It was reported that the splice variant at the COOHterminal of DGKb was related to bipolar disorder (57) . Furthermore, the abnormal behaviors of DGKb KO mice were partly reversed using lithium or methyl phenidate treatment (32, 60) ; therefore, DGKb KO mice may be a useful animal model for bipolar disease and attention deficit/hyperactivity disorder.
From these findings, DGKb deficiency may affect brain development and lead to abnormal neuropsychiat ric behaviors in adult mice. Furthermore, DGKb is also involved in the molecular machineries of dendrite out growth and spinogenesis of neurons.
DGKg
DGKg is expressed strongly in the cerebellum and moderately in the hippocampal pyramidal cells and dentate granule cell layer. The expression is also detected in the cortex and olfactory bulb (61, 62) . The expression of DGKg in the brain is gradually increased after birth, like it is for DGKb (56). DGKg does not seem to be expressed in the retina (19) . To date, there are no reports of deficient mice.
Type II DGKs
DGKd
Sakane et al. reported that DGKd is not expressed in the central nervous system in humans, including the brain and retina (10). However, Leach et al. reported that DGKd is expressed prominently in pyramidal neurons of the neocortex and hippocampus, as well as within internal granule cell neurons of the cerebellum (33) .
DGKd KO mice were generated by Crotty et al. in 2006 (26) . The mouse pups were born with open eyelids and died shortly after birth (within 24 h), which is similar to epidermal growth factor receptor (EGFR) KO mice (26) . It has been reported that DGKd heterozygous mice develop insulin resistance (63) and that DGKd also affects the EGFR by modulating PKC signaling (26) . Taken together, these findings indicate that DGKd has the potential of regulating the downstream signaling of numerous other tyrosine kinase-type receptors.
KohyamaKoganeya et al. reported that a female patient with a de novo balanced translocation, 46,X,t(X;2) (p11.2;q37)dn, exhibited seizures, capillary abnormalities, developmental delays, infantile hypotonia, and obesity (64) . DGKd is disrupted at 2q37 and involved in central nervous system development and function (33) . Mice with DGKd disruption in the DGAP095 showed abnormal epileptic discharges, and DGKd is also in volved in the etiology of seizures. However, the roles of DGKd in these conditions remain relatively unknown.
DGKh
There exist two isoforms (h1 and h2) and DGKh1 mRNA has been reported to be ubiquitously distributed in various tissues including the brain (40) . A previous report suggested the correlation between bipolar disorder and DGKh (65 -67) . In the patient with bipolar disorder, increased DGKh mRNA levels (66) and four SNPs in the DGKh (67) were reported. Overexpression or mutation of DGKh may allow researchers to reveal the involve ment of DGKh in the pathogenesis of bipolar disorder.
The expression patterns of DGKk were revealed, but its function has not been elucidated (11, 17) .
Type III DGKs
DGKe
DGKe is abundantly expressed in the retina, especially in the INL, outer nuclear layer (ONL), and inner segment layer (ISL), and it is the only isoform expressed in pho toreceptors (18, 19, 64) . In the brain, DGKe is also expressed and distributed in the Purkinje cells of the cerebellum, the pyramidal cells of the hippocampus, the mitral cells of the olfactory bulb, and the neurons of the substantia nigra (27, 64) .
DGKe KO mice were generated by Rodriguez et al. in 2001 (27) . As discussed, DGKb, DGKd, or DGKz deficiency (which is noted in a later chapter) exacerbated seizure phenotypes, but DGKe KO mice showed a higher resistance to seizures induced by electroconvulsive shock (27, 34) . DGKe is the only DGK to exhibit high selectivity for arachidonatecontaining substrates (13) . Further, in DGKe KO mice, the phosphatidylinositol 4,5bisphosphatesignaling pathway in the cerebral cortex was greatly affected, leading to lower accumula tion of 20:4DAG and free 20:4, and seizures were decreased compared with wildtype mice (27) . In normal conditions, DGKeKO mice had lower PI content with 1stearoyl2arachidonoyl acyl chains (68) .
In the striatum of R6/2 Huntington disease transgenic mice and Hdh 111Q/111Q cells (a mouse Huntington disease striatal cell model), the expression levels of DGKe have been found to increase. Furthermore, the knockdown of DGKe or pharmacological inhibition using DGK inhibitor I (also known as R59022) signifi cantly ameliorates the toxic effects of expanded Hunting tin in Drosophila and Hdh 111Q/111Q cells (69) . Further research is needed to reveal the roles of DGKe using DGKe KO mice.
Type IV DGKs
DGKz
DGKz is expressed strongly in the cerebellum, hippo campal pyramidal and dentate granular cells, olfactory bulb, and dense cerebral cortex (14) . Furthermore, in the retinas, DGKz is expressed in the GCL, OPL, INL, and IPL and localized in rod and cone bipolar cells, hori zontal cells, amacrine cells, and ganglion cells (18, 19) .
DGKz KO mice were generated by Zhong et al. in 2003 (28) . In hippocampal slices of DGKzKO mice, PA production has also been found to decrease after stimula tion, and the spine density of hippocampal CA1 pyrami dal neurons are significantly reduced, suggesting that DGKz is required to maintain dendritic spines (30) . Furthermore, Schaffer collateralCA1 pyramidal syn apses in the hippocampus of DGKzKO mice showed enhanced longterm potentiation (LTP) and attenuated longterm depression (LTD) (70) . In dendric spine main tenance, DGKz also plays an important role by not only affecting the PA production, but also interacting or forming a multiprotein complex with PSD95, p21 activated kinase 1 (PAK1), RASrelated C3 botulinus toxin substrate 1 (Rac1), and others (30, 71) . However, the behavioral analysis of cognitive function or other higher brain functions has not yet been reported and therefore, further research is needed to confirm DGKz's involvement in brain function.
After several excitatory stimuli, the localization of DGKz has been found to change dramatically from the nucleus to the cytoplasm and degraded (72 -74) . DGKz is involved in early events of the apoptotic cell death pathway. Indeed, in DGKz KO mice, kainic acid has caused serious convulsive seizures and neuronal cell death in the hippocampus compared with wildtype mice (35) . On the other hand, DGKzimmunoreactivity is also detected in nonneuronal cells such as microglia in pathological conditions (75) . These findings indicate that DGKz plays several important roles in nonneuronal cells.
DGKi
DGKi is expressed in the brain and retinas (15) . In the brain, DGKi is strongly expressed in the hippocampal calcium region and dentate gyrus, and it is moderately expressed in the cortex and striatum (76) . In the retinas, its expression is detected mainly in the postsybaptic region of rod bipolar dendrites in the OPL (18) .
DGKi KO mice were generated by Regier et al. in 2005 (29) . In the hippocampus of these mice, there is a small increase in the presynaptic release probability and a reduction in metabotropic glutamate receptordependent LTD, although their dendritic spines are not affected. The behavioral analyses indicate that DGKi KO mice seemed to take more time to habituate to a novel environment, but there are no changes in their locomotor activity, anxietylike behavior, or spatial learning and memory (31) . In another study, it has been reported that the expression levels of DGKi are up regulated in the cortex of alcohol accepting rats com pared with alcohol nonaccepting rats (76) . These findings indicate that DGKiKO mice exhibit different phenotypes in various behavioral tests such as alcohol accepting tests.
Type V DGKs
DGKq is expressed strongly in the cerebellar cortex and hippocampus, and it is moderately in the olfactory bulb and brain stem nuclei (16) . The expression of DGKq during the orgnanogenesis of mouse embryos has been studied in detail (77) . DGKq is expressed prominently in the brain during the early stage of development and these results may demonstrated the potential of the involve ment in the development of the brain. However, at pres ent, there are no reports that have discussed its expression in the retina or its function.
Discussion
In this review, we discussed the roles of DGKs in the central nervous system, which have been revealed mainly from genetic models.
DGKb and DGKz are comparatively well studied, but other isoforms have not been investigated extensively. Overall, DGK deficiencies cause an imbalance between DG and PA and affect other types of cellular signalings. However, the role of specific DGKs differ from one another based on their localization or structures.
DGKs are reported to be expressed mainly in the brain, but their expression is also detected in other regions such the retina. However in the central nervous system, most studies were performed to reveal the roles of DGKs in the brain. In Drosophia, the rdgA mutatation, which leads to a lack of eyespecific and membraneassociated DGK activity, caused photoreceptor cell degeneration (78) . In the other reports, it has been suggested that rdgA is essential for photoreceptor maintenance (79, 80) .
Taken together, these findings suggest that DGKs are also important in the retina, but additional research is needed to clarify their roles.
To date, there is no compound that activates or inhibits the limited isoforms of DGKs. Hence, it is essential to understand the roles of DGKs and to generate an activator or inhibitor that exhibits selectivity to each isoform.
Conclusion
In the central nervous system, various isoforms of DGKs are expressed and play their own roles, which differ from one to another. It may be useful to understand the roles of each DGK to clarify the pathogenesis of various disorders related to DGKs in the central nervous system.
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